Suspension HEK293 cell line platform
Our GMP-compliant suspension HEK293 cell lines are optimised for rAAV, lentiviral and adenoviral vector production, and accelerate the development of gene therapy targets.
Engineered derivatives include the HEK293OX_BCD derivative cell line that provides an optimised transient AAV and lentiviral production platform, and is designed for seamless transition between transient manufacture and stable packaging and producer cell lines. Another is the Tet-R variant, specifically designed for viral vectors containing cytotoxic transgenes. Our cell lines contain no SV40 T-antigen and can grow without antibiotics, minimising regulatory risks in clinical use.
Download the resource to read on...